Nephros (NEPH) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)
Nephros (NEPH) Net Income towards Common Stockholders Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 23.94% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -34.15% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 0.98% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -58.26% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 16.64% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 3.33% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -188.83% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 38.46% |
| 10 | Nephros | 45.71 Mn | 41.01 Mn | 4.03 Mn | 405.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 405.06% |
| Mar 31, 2026 | 103.23% |
| Dec 31, 2025 | -82.97% |
| Sep 30, 2025 | 84.15% |
| Jun 30, 2025 | 182.01% |
| Mar 31, 2025 | -332.21% |
| Dec 31, 2024 | 155.66% |
| Sep 30, 2024 | 200.55% |
| Jun 30, 2024 | 33.26% |
| Mar 31, 2024 | 32.03% |
| Dec 31, 2023 | 28.76% |
| Sep 30, 2023 | 94.37% |
| Jun 30, 2023 | 64.01% |
| Mar 31, 2023 | 84.93% |
| Dec 31, 2022 | 16.77% |
| Sep 30, 2022 | -164.40% |
| Jun 30, 2022 | -1.43% |
| Mar 31, 2022 | -240.60% |
| Dec 31, 2021 | -34.51% |
| Sep 30, 2021 | -13.99% |